Temat: "Cell Death" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Mechanisms of Regulated Cell Death: Current Perspectives.
Autorzy :: Santagostino SF; 7412Genentech, Inc, South San Francisco, CA, USA.
Assenmacher CA; Department of Pathobiology, School of Veterinary Medicine, 6572University of Pennsylvania, Philadelphia, PA, USA.
Tarrant JC; Department of Pathobiology, School of Veterinary Medicine, 6572University of Pennsylvania, Philadelphia, PA, USA.
Adedeji AO; 7412Genentech, Inc, South San Francisco, CA, USA.
Radaelli E; Department of Pathobiology, School of Veterinary Medicine, 6572University of Pennsylvania, Philadelphia, PA, USA.; Pokaż więcej
Źródło :: Veterinary pathology [Vet Pathol] 2021 Jul; Vol. 58 (4), pp. 596-623. Date of Electronic Publication: 2021 May 27.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Regulated Cell Death*
Animals ; Apoptosis ; Cell Death ; Necrosis/veterinary ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
Autorzy :: Song CW; Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota. Electronic address: .
Glatstein E; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Marks LB; Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.
Emami B; Department of Radiation Oncology, Loyola University Medical Center, Chicago, Illinois.
Grimm J; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
Sperduto PW; Minneapolis Radiation Oncology and Gamma Knife Center, University of Minnesota, Minneapolis, Minnesota.
Kim MS; Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Hui S; Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.
Dusenbery KE; Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.
Cho LC; Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.; Pokaż więcej
Źródło :: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 May 01; Vol. 110 (1), pp. 21-34. Date of Electronic Publication: 2019 Mar 02.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Cell Death*/genetics
Neoplasms/*radiotherapy
Radiosurgery/*methods
Animals ; Blood Vessels/pathology ; Blood Vessels/radiation effects ; Carcinoma 256, Walker/blood supply ; Carcinoma 256, Walker/pathology ; Carcinoma 256, Walker/radiotherapy ; Cell Survival/radiation effects ; DNA Damage ; Dose Fractionation, Radiation ; Endothelium, Vascular/cytology ; Humans ; Immunogenic Cell Death ; Mice ; Mice, Nude ; Neoplasms/blood supply ; Neoplasms/immunology ; Organs at Risk/blood supply ; Organs at Risk/radiation effects ; Radiobiology ; Rats ; Tumor Hypoxia/radiation effects ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
Autorzy :: Spurrier MA; Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC.
Jennings-Gee JE; Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC.
Daly CA; Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC.
Haas KM; Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC .; Pokaż więcej
Źródło :: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Oct 15; Vol. 207 (8), pp. 1978-1989. Date of Electronic Publication: 2021 Sep 17.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: B-Lymphocytes/*immunology
Pneumococcal Infections/*immunology
Pneumococcal Vaccines/*immunology
Programmed Cell Death 1 Receptor/*metabolism
T-Lymphocytes/*immunology
Animals ; B7-H1 Antigen/metabolism ; Homeostasis ; Immunity, Humoral ; Immunogenicity, Vaccine ; Immunologic Memory ; Lymphocyte Activation ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Programmed Cell Death 1 Ligand 2 Protein/metabolism ; Protein Binding ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: PD-1 signaling pathway in sepsis: Does it have a future?
Autorzy :: Chen R; Department of Intensive care unit, The First People's Hospital of Foshan, Foshan 528000, Guangdong Province, China; Sun Yet-sen University, Guangzhou 510000, Guangdong Province, China.
Zhou L; Department of Intensive care unit, The First People's Hospital of Foshan, Foshan 528000, Guangdong Province, China. Electronic address: .; Pokaż więcej
Źródło :: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Aug; Vol. 229, pp. 108742. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Programmed Cell Death 1 Receptor/*immunology
Sepsis/*immunology
Adaptive Immunity ; Animals ; B-Lymphocytes/immunology ; B7-H1 Antigen/immunology ; Dendritic Cells/immunology ; Humans ; Immune Tolerance ; Immunity, Innate ; Immunotherapy ; Macrophages/immunology ; Models, Immunological ; Monocytes/immunology ; Neutrophils/immunology ; Prognosis ; Programmed Cell Death 1 Ligand 2 Protein/immunology ; Sepsis/therapy ; Signal Transduction/immunology ; T-Lymphocytes/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Autorzy :: Xie L; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Wang G; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Sang W; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Li J; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Zhang Z; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Li W; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Yan J; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Zhao Q; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Dai Y; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China. Electronic address: .; Pokaż więcej
Źródło :: Biomaterials [Biomaterials] 2021 Feb; Vol. 269, pp. 120638. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenic Cell Death*
Immunotherapy*
Neoplasms*/drug therapy
Doxorubicin ; Humans ; Immune Checkpoint Inhibitors ; Nanoparticles ; Polyphenols ; Programmed Cell Death 1 Receptor ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Lycopene prevents oxygen-glucose deprivation-induced autophagic death in SH-SY5Y cells via inhibition of the oxidative stress-activated AMPK/mTOR pathway.
Autorzy :: Li T; Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Zhang Y; Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Qi Y; Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Liu H; Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.; Pokaż więcej
Źródło :: Molecular medicine reports [Mol Med Rep] 2021 Aug; Vol. 24 (2). Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :: Journal Article
MeSH Terms :: Autophagic Cell Death/*drug effects
Glucose/*metabolism
Lycopene/*pharmacology
Neuroprotective Agents/*pharmacology
Oxidative Stress/*drug effects
Oxygen/*metabolism
Signal Transduction/*drug effects
TOR Serine-Threonine Kinases/*metabolism
AMP-Activated Protein Kinases/metabolism ; Apoptosis/drug effects ; Autophagy/drug effects ; Cell Death/drug effects ; Cell Line, Tumor ; Humans ; Neuroblastoma ; Neurons ; Up-Regulation/drug effects
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.
Autorzy :: Panagioti E; Department of Molecular Medicine and.; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Harvey W. Cushing Neuro-oncology Laboratories (HCNL), Department of Neurosurgery, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
Kurokawa C; Department of Molecular Medicine and.; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Viker K; Department of Molecular Medicine and.; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Ammayappan A; Department of Molecular Medicine and.; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Anderson SK; Department of Quantitative Health Sciences.
Sotiriou S; Department of Laboratory Medicine and Pathology, and.
Chatzopoulos K; Department of Laboratory Medicine and Pathology, and.
Ayasoufi K; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Johnson AJ; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Iankov ID; Department of Molecular Medicine and.; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Galanis E; Department of Molecular Medicine and.; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Pokaż więcej
Źródło :: The Journal of clinical investigation [J Clin Invest] 2021 Jul 01; Vol. 131 (13).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Antigens, Bacterial/*therapeutic use
Brain Neoplasms/*therapy
Glioblastoma/*therapy
Oncolytic Virotherapy/*methods
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Animals ; Antigens, Bacterial/administration & dosage ; Antigens, Bacterial/genetics ; Bacterial Proteins/genetics ; Bacterial Proteins/immunology ; Bacterial Proteins/therapeutic use ; Brain Neoplasms/immunology ; Brain Neoplasms/pathology ; CD8-Positive T-Lymphocytes/immunology ; Cell Death/immunology ; Cell Line, Tumor ; Combined Modality Therapy ; Cytokines/metabolism ; Cytopathogenic Effect, Viral ; Female ; Glioblastoma/immunology ; Glioblastoma/pathology ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Measles virus/genetics ; Measles virus/immunology ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Nude ; Oncolytic Viruses/genetics ; Oncolytic Viruses/immunology ; Receptors, Urokinase Plasminogen Activator/immunology ; Translational Medical Research ; Virus Internalization
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.
Autorzy :: Shim YJ; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Khedraki R; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Dhar J; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Fan R; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Dvorina N; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Valujskikh A; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Fairchild RL; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
Baldwin WM 3rd; Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA. Electronic address: .; Pokaż więcej
Źródło :: Kidney international [Kidney Int] 2020 Oct; Vol. 98 (4), pp. 897-905. Date of Electronic Publication: 2020 Apr 25.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Kidney Transplantation*
Programmed Cell Death 1 Receptor*
Animals ; B7-H1 Antigen ; CD8-Positive T-Lymphocytes ; Cell Death ; Ligands ; Mice ; Mice, Inbred C57BL
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target.
Autorzy :: Ponce de León C; Department of Experimental Biology, Faculty of Health Sciences, University of Jaén, Jaén, Spain.
Lorite P; Department of Experimental Biology, Faculty of Health Sciences, University of Jaén, Jaén, Spain.
López-Casado MÁ; Department of Pediatric Gastroenterology, Virgen de las Nieves Hospital, Granada, Spain.
Barro F; Department of Plant Genetic Improvement, Institute for Sustainable Agriculture, Spanish National Research Council (CSIC), Córdoba, Spain.
Palomeque T; Department of Experimental Biology, Faculty of Health Sciences, University of Jaén, Jaén, Spain.
Torres MI; Department of Experimental Biology, Faculty of Health Sciences, University of Jaén, Jaén, Spain.; Pokaż więcej
Źródło :: Frontiers in immunology [Front Immunol] 2021 Jun 16; Vol. 12, pp. 678400. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Alternative Splicing*
Gene Expression Regulation*
Celiac Disease/*genetics
Programmed Cell Death 1 Receptor/*genetics
B7-H1 Antigen/metabolism ; Biomarkers ; Celiac Disease/diagnosis ; Celiac Disease/metabolism ; Celiac Disease/therapy ; Child ; Cytokines/biosynthesis ; Disease Susceptibility ; Female ; Humans ; Immunohistochemistry ; Interferon-gamma/metabolism ; Male ; Peptides/immunology ; Peptides/metabolism ; Polymorphism, Single Nucleotide ; Prognosis ; Programmed Cell Death 1 Ligand 2 Protein/metabolism ; Programmed Cell Death 1 Receptor/metabolism ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Autorzy :: Zhou L; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
Zhang P; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China.
Wang H; China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
Wang D; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China.
Li Y; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China.; Pokaż więcej
Źródło :: Accounts of chemical research [Acc Chem Res] 2020 Sep 15; Vol. 53 (9), pp. 1761-1772. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenic Cell Death*/drug effects
Immunotherapy*
Drug Carriers/*chemistry
Nanostructures/*chemistry
Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/chemistry ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Indoleamine-Pyrrole 2,3,-Dioxygenase/antagonists & inhibitors ; Indoleamine-Pyrrole 2,3,-Dioxygenase/chemistry ; Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism ; Ligands ; Neoplasms/therapy ; Polymers/chemistry ; Prodrugs/chemistry ; Prodrugs/pharmacology ; Prodrugs/therapeutic use ; Programmed Cell Death 1 Receptor/chemistry ; Programmed Cell Death 1 Receptor/metabolism ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
Autorzy :: Lu Y; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Xu F; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Wang Y; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Shi C; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Sha Y; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
He G; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Yao Q; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Shao K; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China.
Sun W; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China; State Key Laboratory of Fine Chemicals, Shenzhen Research Institute, Dalian University of Technology, Nanshan District, Shenzhen, 518057, PR China.
Du J; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China; State Key Laboratory of Fine Chemicals, Shenzhen Research Institute, Dalian University of Technology, Nanshan District, Shenzhen, 518057, PR China.
Fan J; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China; State Key Laboratory of Fine Chemicals, Shenzhen Research Institute, Dalian University of Technology, Nanshan District, Shenzhen, 518057, PR China.
Peng X; State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, PR China; State Key Laboratory of Fine Chemicals, Shenzhen Research Institute, Dalian University of Technology, Nanshan District, Shenzhen, 518057, PR China. Electronic address: .; Pokaż więcej
Źródło :: Biomaterials [Biomaterials] 2021 Nov; Vol. 278, pp. 121167. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenic Cell Death*
Neoplasms*/drug therapy
Humans ; Immunotherapy ; Indoleamine-Pyrrole 2,3,-Dioxygenase ; Pyroptosis ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Rapid, sensitive and cost-effective determination of immune checkpoint inhibitor activity using a magnetic bead-based binding assay.
Autorzy :: Meng Q; Institute of Biomedical Sciences, The Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Shanxi University, Taiyuan, Shanxi Province 030006, China. Electronic address: .
Fu Y; Institute of Biomedical Sciences, The Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Shanxi University, Taiyuan, Shanxi Province 030006, China.
Li S; Institute of Biomedical Sciences, The Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Shanxi University, Taiyuan, Shanxi Province 030006, China.
Yan Y; Department of Infectious diseases, Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu Province 215013, China.
Duan D; Chengdu Newgenegle Clinical Diagnosis Lab, Chengdu, Sichuan Province 610041, China.
Anthony DD; Departments of Medicine and Pathology, Divisions of Infectious and Rheumatic Diseases, VA Northeast Ohio Healthcare System and MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Zhu Y; Department of Infectious diseases, Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu Province 215013, China.
Wu X; Department of Infectious diseases, Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu Province 215013, China.
Qian F; Department of Infectious diseases, Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu Province 215013, China. Electronic address: .
Wu C; Institute of Biomedical Sciences, The Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Shanxi University, Taiyuan, Shanxi Province 030006, China. Electronic address: .; Pokaż więcej
Źródło :: Journal of immunological methods [J Immunol Methods] 2021 Nov; Vol. 498, pp. 113134. Date of Electronic Publication: 2021 Aug 28.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immune Checkpoint Inhibitors/*pharmacology
Immunoassay/*economics
Nivolumab/*pharmacology
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Receptors, Immunologic/*antagonists & inhibitors
Animals ; Antibodies, Monoclonal/immunology ; Antibody Specificity ; CHO Cells ; Cell Line, Tumor ; Cost Savings ; Cost-Benefit Analysis ; Cricetulus ; Enzyme-Linked Immunosorbent Assay/economics ; Flow Cytometry/economics ; HEK293 Cells ; Humans ; Mice ; Predictive Value of Tests ; Programmed Cell Death 1 Receptor/immunology ; Programmed Cell Death 1 Receptor/metabolism ; Receptors, Immunologic/immunology ; Receptors, Immunologic/metabolism ; Reproducibility of Results ; Time Factors ; Workflow
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma.
Autorzy :: He C; Medical School of Southeast University, Nanjing, People's Republic of China.
Ding H; Medical School of Southeast University, Nanjing, People's Republic of China.
Chen J; Medical School of Southeast University, Nanjing, People's Republic of China.
Ding Y; Medical School of Southeast University, Nanjing, People's Republic of China.
Yang R; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, People's Republic of China.
Hu C; Department of Tuberculosis, The Second Affiliated Hospital of Southeast University (The Second Hospital of Nanjing), Nanjing, People's Republic of China.
An Y; Medical School of Southeast University, Nanjing, People's Republic of China.
Liu D; Medical School of Southeast University, Nanjing, People's Republic of China.
Liu P; Medical School of Southeast University, Nanjing, People's Republic of China.
Tang Q; Medical School of Southeast University, Nanjing, People's Republic of China.
Zhang Z; Department of Neurosurgery, Nanjing Jinling Hospital, Nanjing University, Nanjing, People's Republic of China.; Pokaż więcej
Źródło :: International journal of nanomedicine [Int J Nanomedicine] 2021 Oct 22; Vol. 16, pp. 7123-7135. Date of Electronic Publication: 2021 Oct 22 (Print Publication: 2021).
Typ publikacji :: Journal Article
MeSH Terms :: Glioblastoma*/therapy
Immunogenic Cell Death*
Cell Line, Tumor ; Chemoradiotherapy ; Humans ; Hydrogen-Ion Concentration
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: The roles of GTPase-activating proteins in regulated cell death and tumor immunity.
Autorzy :: He H; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Huang J; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Wu S; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Jiang S; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Liang L; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Liu Y; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China.
Liu W; Department of Head and Neck Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
Xie L; Department of Head and Neck Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
Tao Y; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Department of Pathology, Xiangya Hospital, School of Basic Medicine, Central South University, Changsha, 410078, Hunan, People's Republic of China.
Jiang Y; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China. .; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China. .
Cong L; The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China. .; School of Medicine, Hunan Normal University, Changsha, 410013, Hunan, People's Republic of China. .; Pokaż więcej
Źródło :: Journal of hematology & oncology [J Hematol Oncol] 2021 Oct 18; Vol. 14 (1), pp. 171. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Regulated Cell Death*
GTPase-Activating Proteins/*immunology
Neoplasms/*immunology
Animals ; GTP Phosphohydrolases/immunology ; Guanosine Triphosphate/immunology ; Humans ; Neoplasms/pathology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.
Autorzy :: Prakadan SM; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA.
Alvarez-Breckenridge CA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Markson SC; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kim AE; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Klein RH; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nayyar N; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Navia AW; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA.
Kuter BM; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Kolb KE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA.
Bihun I; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Mora JL; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Bertalan MS; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Shaw B; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
White M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Kaplan A; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Stocking JH; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Wadsworth MH 2nd; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA.
Lee EQ; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Chukwueke U; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Wang N; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Subramanian M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Rotem D; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.
Cahill DP; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.
Adalsteinsson VA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.
Miller JW; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA.
Sullivan RJ; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Carter SL; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. .; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. .; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA. .
Brastianos PK; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. .; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA. .; Massachusetts General Hospital Cancer Center, Boston, MA, USA. .
Shalek AK; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. .; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA. .; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. .; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. .; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA. .; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, USA. .; Program in Computational & Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. .; Pokaż więcej
Źródło :: Nature communications [Nat Commun] 2021 Oct 12; Vol. 12 (1), pp. 5955. Date of Electronic Publication: 2021 Oct 12.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Brain Neoplasms/*drug therapy
CTLA-4 Antigen/*immunology
Immune Checkpoint Inhibitors/*therapeutic use
Meningeal Carcinomatosis/*drug therapy
Meningeal Neoplasms/*drug therapy
Programmed Cell Death 1 Receptor/*immunology
Tumor Microenvironment/*drug effects
Adult ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Brain Neoplasms/immunology ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/genetics ; Cell-Free Nucleic Acids/genetics ; Cell-Free Nucleic Acids/immunology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunotherapy ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Ipilimumab/therapeutic use ; Male ; Meningeal Carcinomatosis/immunology ; Meningeal Carcinomatosis/mortality ; Meningeal Carcinomatosis/pathology ; Meningeal Neoplasms/immunology ; Meningeal Neoplasms/mortality ; Meningeal Neoplasms/pathology ; Middle Aged ; Nivolumab/therapeutic use ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/genetics ; Single-Cell Analysis ; Survival Analysis ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Healthy Tissue Damage Following Cancer Ion Therapy: A Radiobiological Database Predicting Lymphocyte Chromosome Aberrations Based on the BIANCA Biophysical Model.
Autorzy :: Embriaco A; ISezione di Pavia, INFN (Italian National Institute for Nuclear Physics), Via Bassi 6, 27100 Pavia, Italy.; Istituto Nazionale di Metrologia delle Radiazioni Ionizzanti, ENEA, 00123 Roma, Italy.
Ramos R; ISezione di Pavia, INFN (Italian National Institute for Nuclear Physics), Via Bassi 6, 27100 Pavia, Italy.
Carante M; ISezione di Pavia, INFN (Italian National Institute for Nuclear Physics), Via Bassi 6, 27100 Pavia, Italy.; Physics Department, University of Pavia, Via Bassi 6, 27100 Pavia, Italy.
Ferrari A; University Hospital Heidelberg, 69120 Heidelberg, Germany.; Gangneung-Wonju National University, Gangneung 25457, Korea.
Sala P; Sezione di Milano, INFN (Italian National Institute for Nuclear Physics), Via Celoria 16, 20133 Milano, Italy.
Vercesi V; ISezione di Pavia, INFN (Italian National Institute for Nuclear Physics), Via Bassi 6, 27100 Pavia, Italy.
Ballarini F; ISezione di Pavia, INFN (Italian National Institute for Nuclear Physics), Via Bassi 6, 27100 Pavia, Italy.; Physics Department, University of Pavia, Via Bassi 6, 27100 Pavia, Italy.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 08; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :: Journal Article
MeSH Terms :: Cell Death*
Monte Carlo Method*
Relative Biological Effectiveness*
Chromosome Aberrations/*radiation effects
Heavy Ion Radiotherapy/*adverse effects
Lymphocytes/*pathology
Neoplasms/*radiotherapy
Biophysics ; Humans ; Lymphocytes/drug effects
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Role of Extracellular Vesicles in Cell Death and Inflammation.
Autorzy :: Sanwlani R; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3083, Australia.
Gangoda L; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3083, Australia.; The Walter and Eliza Hall Institute of Medical Research (WEHI), 1G Royal Parade, Parkville, Melbourne, VIC 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Melbourne, VIC 3010, Australia.; Pokaż więcej
Źródło :: Cells [Cells] 2021 Oct 05; Vol. 10 (10). Date of Electronic Publication: 2021 Oct 05.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Apoptosis*
Cell Death*
SARS-CoV-2*
COVID-19/*therapy
Extracellular Vesicles/*metabolism
Inflammation/*metabolism
Lung/*pathology
Sepsis/*immunology
Animals ; Biomarkers/metabolism ; COVID-19/immunology ; Cell Communication ; Chemokines ; Exosomes ; Humans ; Lung/immunology ; Mice ; Sepsis/physiopathology
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Multifunctional carbon monoxide nanogenerator as immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect.
Autorzy :: Xiao X; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.
Liang S; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.
Zhao Y; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.
Pang M; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.
Ma P; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.
Cheng Z; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China. Electronic address: .
Lin J; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China. Electronic address: .; Pokaż więcej
Źródło :: Biomaterials [Biomaterials] 2021 Oct; Vol. 277, pp. 121120. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunogenic Cell Death*
Pharmaceutical Preparations*
Carbon Monoxide ; Immunotherapy ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Antagonizing effects of curcumin against mercury-induced autophagic death and trace elements disorder by regulating PI3K/AKT and Nrf2 pathway in the spleen.
Autorzy :: Zhao G; Department of Core Medical Laboratory, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, PR China.
Qi L; Department of Core Medical Laboratory, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, PR China.
Wang Y; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China.
Li X; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China.
Li Q; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China.
Tang X; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China.
Wang X; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China.
Wu C; Department of Pathophysiology, College of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, Sichuan Province, PR China. Electronic address: .; Pokaż więcej
Źródło :: Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2021 Oct 01; Vol. 222, pp. 112529. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :: Journal Article
MeSH Terms :: Autophagic Cell Death*
Curcumin*/pharmacology
Mercury*/toxicity
Trace Elements*
Animals ; Mice ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Oxidative Stress ; Phosphatidylinositol 3-Kinase ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Spleen/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma.
Autorzy :: Fukushima H; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Yoshida S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Kijima T; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Nakamura Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Fukuda S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Uehara S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Yasuda Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Tanaka H; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Yokoyama M; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Matsuoka Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Fujii Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2021 Jan 07; Vol. 22 (2). Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :: Journal Article
MeSH Terms :: Carcinoma/*drug therapy
Carcinoma/*radiotherapy
Cisplatin/*pharmacology
Immunogenic Cell Death/*drug effects
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Carcinoma/genetics ; Carcinoma/pathology ; Chemoradiotherapy ; Combined Modality Therapy ; Heterografts ; Humans ; Mice ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/genetics ; Urothelium/drug effects ; Urothelium/pathology ; Urothelium/radiation effects
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cell Death"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język